Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Sino Biopharma’s PD-L1 Combo with Anlotinib Accepted for Review by China’s CDE
January 24, 2025
Company
Deals
Meheco’s Genertec Partners with AstraZeneca for COVID-19 Antibody Evusheld in China
January 24, 2025
Company
Drug
Guangzhou’s Overseas Pharma Wins China Clinical Trial Approval for OPL-038
January 24, 2025
Company
Deals
Eyougene Raises Hundreds of Millions in Series B Funding for Expansion
January 25, 2025
Company
Deals
LePure Bio Secures Hundreds of Millions in Series C Funding for Expansion
January 24, 2025
Company
Deals
Shenzhen Keyto Fluid Control Secures Series C Funding for Expansion
January 24, 2025
Company
Drug
Xinhua Pharma’s OAB-14 Receives NMPA Approval for Phase I Alzheimer’s Study
January 24, 2025
Company
Deals
Cii Tech Secures Tens of Millions in Pre-Series A Funding for Mass Spectrometry
January 24, 2025
Company
Deals
TechnoDerma Raises Series A+ Funding to Advance Dermatology Pipeline
January 24, 2025
Company
Drug
Konruns’ KC1036 Advances to Phase II Study for Lung Adenocarcinoma
January 24, 2025
Company
Drug
Harbour BioMed’s HBM1020 Receives FDA Approval for US Phase I Study
January 24, 2025
Company
Porton Pharma Solutions to Invest EUR 50 Million in Slovenia Bio-Industry Park
January 24, 2025
1
2
…
1,049
1,050
1,051
1,052
1,053
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?